These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 25055198

  • 41. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
    Kim MJ, Rhee HJ, Jeong HT.
    AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
    [Abstract] [Full Text] [Related]

  • 42. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B, Frulio N, Laumonier H, Salut C, Lafitte L, Trillaud H.
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [Abstract] [Full Text] [Related]

  • 43. Association Between Gadoxetic Acid-Enhanced Magnetic Resonance Imaging, Organic Anion Transporters, and Farnesoid X Receptor in Benign Focal Liver Lesions.
    van Rosmalen BV, Visentin M, Furumaya A, van Delden OM, Kazemier G, van Gulik TM, Verheij J, Stieger B.
    Drug Metab Dispos; 2024 Jan 09; 52(2):118-125. PubMed ID: 38050024
    [Abstract] [Full Text] [Related]

  • 44. [Focal nodular hyperplasia and hepatocellular adenoma].
    Bastati-Huber N, Pötter-Lang S, Ba-Ssalamah A.
    Radiologe; 2015 Jan 09; 55(1):18-26. PubMed ID: 25575723
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations.
    Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, Helmberger TK, Reiser MF.
    Radiology; 2005 Feb 09; 234(2):468-78. PubMed ID: 15591431
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
    Shih A, Lauwers GY, Balabaud C, Bioulac-Sage P, Misdraji J.
    Am J Surg Pathol; 2015 Sep 09; 39(9):1296-300. PubMed ID: 26274031
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
    Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA.
    Radiographics; 2004 Sep 09; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
    [Abstract] [Full Text] [Related]

  • 55. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N, Genrich G, Ferrell L, Kakar S.
    Hum Pathol; 2014 May 09; 45(5):976-83. PubMed ID: 24746201
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.
    Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.
    Abdom Radiol (NY); 2017 Mar 09; 42(3):825-832. PubMed ID: 27704147
    [Abstract] [Full Text] [Related]

  • 60. Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: a role for angiopoietin-1.
    Gouw AS, Zeng W, Buiskool M, Platteel I, van den Heuvel MC, Poppema S, de Jong KP, Molema G.
    Hepatology; 2010 Aug 09; 52(2):540-9. PubMed ID: 20683953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.